Dalton King

1.5k total citations
26 papers, 1.0k citations indexed

About

Dalton King is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Dalton King has authored 26 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Organic Chemistry and 9 papers in Oncology. Recurrent topics in Dalton King's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Peptidase Inhibition and Analysis (6 papers) and Chemical Synthesis and Analysis (5 papers). Dalton King is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Peptidase Inhibition and Analysis (6 papers) and Chemical Synthesis and Analysis (5 papers). Dalton King collaborates with scholars based in United States, Germany and Switzerland. Dalton King's co-authors include Raymond A. Firestone, Pamela A. Trail, Shirley J. Lasch, David Willner, Sandra J. Hofstead, Gene M. Dubowchik, Gary R. Braslawsky, Robert S. Greenfield, John Goers and Thomas J. McKearn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Biochemistry.

In The Last Decade

Dalton King

26 papers receiving 985 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dalton King United States 17 463 436 314 294 117 26 1.0k
Jinhe Pan Canada 19 387 0.8× 472 1.1× 286 0.9× 235 0.8× 184 1.6× 37 1.2k
Alberto Dal Corso Italy 18 637 1.4× 378 0.9× 411 1.3× 316 1.1× 118 1.0× 39 1.0k
Florian Reichart Germany 17 641 1.4× 155 0.4× 253 0.8× 228 0.8× 142 1.2× 24 1.1k
Elisabeth Lohof Germany 6 1.1k 2.3× 214 0.5× 200 0.6× 647 2.2× 89 0.8× 8 1.4k
Franciscus M. H. de Groot Netherlands 12 519 1.1× 197 0.5× 312 1.0× 305 1.0× 128 1.1× 15 954
Sandra J. Hofstead United States 14 728 1.6× 659 1.5× 636 2.0× 417 1.4× 181 1.5× 14 1.6k
João P. M. Nunes United Kingdom 15 304 0.7× 338 0.8× 284 0.9× 462 1.6× 31 0.3× 19 939
Daniela Arosio Italy 29 1.2k 2.5× 427 1.0× 355 1.1× 474 1.6× 306 2.6× 72 1.8k
Michael A. Dechantsreiter Germany 10 690 1.5× 204 0.5× 179 0.6× 345 1.2× 65 0.6× 12 1.1k
Maria Paravatou‐Petsotas Greece 19 243 0.5× 374 0.9× 296 0.9× 191 0.6× 132 1.1× 40 954

Countries citing papers authored by Dalton King

Since Specialization
Citations

This map shows the geographic impact of Dalton King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalton King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalton King more than expected).

Fields of papers citing papers by Dalton King

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dalton King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalton King. The network helps show where Dalton King may publish in the future.

Co-authorship network of co-authors of Dalton King

This figure shows the co-authorship network connecting the top 25 collaborators of Dalton King. A scholar is included among the top collaborators of Dalton King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dalton King. Dalton King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weed, Michael R., Laura J. Signor, Mark Bookbinder, et al.. (2017). Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning. PLoS ONE. 12(12). e0187609–e0187609. 10 indexed citations
2.
King, Dalton, Ivar M. McDonald, James A. Cook, et al.. (2017). Design and synthesis of a novel series of 4-heteroarylamino-1′-azaspiro[oxazole-5,3′-bicyclo[2.2.2]octanes as α7 nicotinic receptor agonists 2. Development of 4-heteroaryl SAR. Bioorganic & Medicinal Chemistry Letters. 27(5). 1261–1266. 7 indexed citations
3.
Bristow, Linda J., Digavalli V. Sivarao, Margaret Batchelder, et al.. (2016). The qEEG Signature of Selective NMDA NR2B Negative Allosteric Modulators; A Potential Translational Biomarker for Drug Development. PLoS ONE. 11(4). e0152729–e0152729. 17 indexed citations
4.
Weed, Michael R., Mark Bookbinder, Rudolf N. Cardinal, et al.. (2015). Negative Allosteric Modulators Selective for The NR2B Subtype of The NMDA Receptor Impair Cognition in Multiple Domains. Neuropsychopharmacology. 41(2). 568–577. 15 indexed citations
5.
King, Dalton, Zhaoxing Meng, Jeffrey A. Deskus, et al.. (2010). Conformationally Restricted Homotryptamines. Part 7: 3-cis-(3-Aminocyclopentyl)indoles As Potent Selective Serotonin Reuptake Inhibitors. Journal of Medicinal Chemistry. 53(21). 7564–7572. 13 indexed citations
6.
Denhart, Derek J., Jeffrey A. Deskus, Jonathan L. Ditta, et al.. (2009). Conformationally restricted homotryptamines. Part 5: 3-(trans-2-aminomethylcyclopentyl)indoles as potent selective serotonin reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(15). 4031–4033. 24 indexed citations
7.
King, Dalton, Derek J. Denhart, Jeffrey A. Deskus, et al.. (2007). Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor. Bioorganic & Medicinal Chemistry Letters. 17(20). 5647–5651. 19 indexed citations
8.
Walker, Michael, Dalton King, R. A. Dalterio, et al.. (2004). Monoclonal antibody mediated intracellular targeting of tallysomycin S10b. Bioorganic & Medicinal Chemistry Letters. 14(16). 4323–4327. 14 indexed citations
9.
Mattson, Ronald J., Derek J. Denhart, John D. Catt, et al.. (2004). Aminotriazine 5-HT7 antagonists. Bioorganic & Medicinal Chemistry Letters. 14(16). 4245–4248. 26 indexed citations
10.
Denhart, Derek J., Ashok V. Purandare, John D. Catt, et al.. (2004). Diaminopyrimidine and diaminopyridine 5-HT7 ligands. Bioorganic & Medicinal Chemistry Letters. 14(16). 4249–4252. 10 indexed citations
11.
Hewawasam, Piyasena, Min Ding, Dalton King, et al.. (2003). Synthesis of water-Soluble prodrugs of BMS-191011: A maxi-K channel opener targeted for post-stroke neuroprotection. Bioorganic & Medicinal Chemistry Letters. 13(10). 1695–1698. 17 indexed citations
12.
King, Dalton, et al.. (2003). BR96 conjugates of highly potent anthracyclines. Bioorganic & Medicinal Chemistry Letters. 13(13). 2119–2122. 16 indexed citations
13.
Dubowchik, Gene M., Harold Mastalerz, Michael Walker, et al.. (2002). Doxorubicin immunoconjugates containing bivalent, lysosomally-Cleavable dipeptide linkages. Bioorganic & Medicinal Chemistry Letters. 12(11). 1529–1532. 30 indexed citations
14.
King, Dalton, Gene M. Dubowchik, & Michael Walker. (2002). Facile synthesis of maleimide bifunctional linkers. Tetrahedron Letters. 43(11). 1987–1990. 21 indexed citations
15.
King, Dalton, David Willner, Raymond A. Firestone, et al.. (1999). Monoclonal Antibody Conjugates of Doxorubicin Prepared with Branched Linkers:  A Novel Method for Increasing the Potency of Doxorubicin Immunoconjugates. Bioconjugate Chemistry. 10(2). 279–288. 60 indexed citations
16.
Dubowchik, Gene M., et al.. (1997). Efficient mitomycin C coupling with stable p-nitrophenyl-benzyl carbonates using n-hydroxybenzotriazole as a catalytic additive. Tetrahedron Letters. 38(30). 5261–5264. 8 indexed citations
17.
Firestone, Raymond A., David Willner, Sandra J. Hofstead, et al.. (1996). Synthesis and antitumor activity of the immunoconjugate BR96-Dox. Journal of Controlled Release. 39(2-3). 251–259. 27 indexed citations
18.
Willner, David, Pamela A. Trail, Sandra J. Hofstead, et al.. (1993). (6-Maleimidocaproyl)hydrazone of doxorubicin. A new derivative for the preparation of immunoconjugates of doxorubicin. Bioconjugate Chemistry. 4(6). 521–527. 183 indexed citations
19.
Rodwell, John D., et al.. (1986). Site-specific covalent modification of monoclonal antibodies: in vitro and in vivo evaluations.. Proceedings of the National Academy of Sciences. 83(8). 2632–2636. 189 indexed citations
20.
Bhandary, K. K., et al.. (1984). Visualization of Drug-Nucleic Acid Interactions at Atomic Resolution. IX. Structures ofTwoN,N-Dimethylproflavine: 5-Iodocytidylyl (3′-5′) Guanosine Crystalline Complexes. Journal of Biomolecular Structure and Dynamics. 1(5). 1195–1217. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinhe Pan Breakdown of academic impact, for papers by Alberto Dal Corso Breakdown of academic impact, for papers by Florian Reichart Breakdown of academic impact, for papers by Elisabeth Lohof Breakdown of academic impact, for papers by Franciscus M. H. de Groot Breakdown of academic impact, for papers by Sandra J. Hofstead Breakdown of academic impact, for papers by João P. M. Nunes Breakdown of academic impact, for papers by Daniela Arosio Breakdown of academic impact, for papers by Michael A. Dechantsreiter Breakdown of academic impact, for papers by Maria Paravatou‐Petsotas
Rankless by CCL
2026